Submissions from 2023
Molecular features associated with long survival on tebentafusp in previously untreated metastatic uveal melanoma in a phase 3 trial, M Orloff, Brendan Curti, and See full list of authors in comments
Novel Directions of ADCs in Breast Cancer. Binaytara Foundation Highlights from SABCS 2022; 2023 January 20; Seattle, WA., David B Page
A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer., David B Page, Joanna Pucilowska, Brie Chun, Isaac Kim, Katherine Sanchez, Nicole Moxon, Staci Mellinger, Yaping Wu, Yoshinobu Koguchi, Valerie Conrad, William L Redmond, Maritza Martel, Zhaoyu Sun, Mary B Campbell, Alison Conlin, Anupama Acheson, Reva Basho, Philomena McAndrew, Mary El-Masry, Dorothy Park, Laura Bennetts, Robert S Seitz, Tyler J Nielsen, Kimberly McGregor, Venkatesh Rajamanickam, Brady Bernard, Walter J Urba, and Heather L McArthur
A phase II study of nivolumab plus ipilimumab and androgen receptor antagonist bicalutamide to stimulate thymic T cell generation in HER2-negative metastatic breast cancer, David Page, Allison Conlin, Sasha Stanton, Walter Urba, Will Redmond, and See full list of authors in comments
Association of pathologic complete response with the 27-gene IO score and week 3 IOpath response following neoadjuvant pembrolizumab +/- intralymphatic cytokines in the neoIRX trial, David Page, Will Redmond, Allison Conlin, S Stanton, and See full list of authors in comments
Impact of Sex on Cardiogenic Shock Outcomes: A Cardiogenic Shock Working Group Report, M Pahuja, Jacob Abraham, and See full list of authors in comments
Fellow's Course: Finding your Dream Job, MJ Paisley
Multi-institutional validation of a radiomics-based artificial intelligence method for predicting response to PD-1/PD-L1 immune checkpoint inhibitor (ICI) therapy in stage IV NSCLC, RB Parikh, Brendan Curti, and See full list of authors in comments
Phase 1/2 study of the bispecific 4–1BB and PD-L1 antibody INBRX-105 alone and in combination with pembrolizumab in select solid tumors, JC Park, Rachel Sanborn, and See full list of authors in comments
Management of infusion-related reactions (IRRs) in patients receiving amivantamab in the CHRYSALIS study., Keunchil Park, Joshua K Sabari, Eric B Haura, Catherine A Shu, Alexander Spira, Ravi Salgia, Karen L Reckamp, Rachel E Sanborn, Ramaswamy Govindan, Joshua M Bauml, Joshua C Curtin, John Xie, Amy Roshak, Patricia Lorenzini, Dawn Millington, Meena Thayu, Roland E Knoblauch, and Byoung Chul Cho
On-site treatment of avalanche victims: Scoping review and 2023 recommendations of the international commission for mountain emergency medicine (ICAR MedCom)., M Pasquier, G Strapazzon, A Kottmann, P Paal, K Zafren, K Oshiro, C Artoni, C Van Tilburg, A Sheets, J Ellerton, K McLaughlin, L Gordon, R W Martin, M Jacob, M Musi, M Blancher, C Jaques, and H Brugger
Screening for occult cancer after unprovoked venous thromboembolism: Assessing the current literature and future directions., Sarah S Patel, Derrick Tao, Hannah S McMurry, and Joseph J Shatzel
Multi-parametric assessment of the immune response to a trio immunotherapy in patients with recurrent or metastatic head and neck squamous cell carcinoma, C Paustian, Matthew Taylor, Will Redmond, B Bernard, RB Bell, Carlo Bifulco, Brian Piening, Walter Urba, Bernard Fox, Rom Leidner, and See full list of authors in comments
Arterial, Venous and Lymphedema Management, Alejandro Perez
Lower Extremity Edema: Diagnosis and Management, Alejandro Perez
Tips For Readers: Mesenteric and Renal Arteries, Alejandro Perez
Brief training in ultrasound equips novice clinicians to accurately and reliably measure jugular venous pressure in obese patients., Nicholas Pettit, Benjamin Pedroja, Hsin-Fang Li, and Michael G Sutcliffe
Great mimicker: definite isolated cardiac sarcoidosis masquerading as hypertrophic cardiomyopathy., Tuan Pham, Jacob Abraham, and Farooq H Sheikh
NICUs in the US: levels of acuity, number of beds, and relationships to population factors., Roberta Pineda, Kathryn C R Knudsen, Courtney C Breault, Elizabeth E Rogers, Wendy J Mack, and Alicia Fernandez-Fernandez
Abstract 6764: Multi-parametric comparison of scRNA-seq with CITE-seq and ultrahigh-plex spatial phenotyping of proteins in FFPE head and neck tumor biopsies: An opportunity to generate uniquely comprehensive multi-omic single cell datasets to investigate the tumor microenvironment, Aditya Pratapa, Brady Bernard, Brian D. Piening, Rom Leidner, Bernard A Fox, and See all authors in comments
The role of dendritic cells in radiation-induced immune responses., A Preet Kaur, A Alice, MR Crittenden, and MJ Gough
Toward structuring real-world data: Deep learning for extracting oncology information from clinical text with patient-level supervision., Sam Preston, Mu Wei, Rajesh Rao, Robert Tinn, Naoto Usuyama, Michael Lucas, Yu Gu, Roshanthi Weerasinghe, Soohee Lee, Brian D. Piening, Paul Tittel, Naveen Valluri, Tristan Naumann, Carlo Bifulco, and Hoifung Poon
A Network Landscape of HPVOPC Reveals Methylation Alterations as Significant Drivers of Gene Expression via an Immune-Mediated GPCR Signal., Jesse R Qualliotine, Takuya Nakagawa, Sara Brin Rosenthal, Sayed Sadat, Carmen Ballesteros-Merino, Guorong Xu, Adam Mark, Art Nasamran, J Silvio Gutkind, Kathleen M Fisch, Theresa Guo, Bernard A Fox, Zubair Khan, Alfredo A Molinolo, and Joseph A Califano
Cancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trial., Tulika Ranjan, Soma Sengupta, Michael J Glantz, Richard M Green, Alexander Yu, Dawit Aregawi, Rekha Chaudhary, Ricky Chen, Mario Zuccarello, Christine Lu-Emerson, Hugh D Moulding, Neil Belman, Jon Glass, Aaron Mammoser, Mark Anderson, Jagan Valluri, Nicholas Marko, Jason Schroeder, Steven Jubelirer, Frances Chow, Pier Paolo Claudio, Anthony M Alberico, Seth T Lirette, Krista L Denning, and Candace M Howard
Challenges and opportunities in the development of combination immunotherapy with OX40 agonists., William L Redmond
Enhancement of anti-tumor efficacy of immune checkpoint blockade by alpha-TEA., William L. Redmond, Melissa Kasiewicz, and Emmanuel T Akporiaye
Multimodal single-cell analysis of human TILs across multiple tumor types reveals heterogeneity and potential opportunities for personalized immunotherapy, Will Redmond and See all authors in comments
Advances in Cancer Immunotherapy, WL Redmond
Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry., Charles J Robbins, Aileen I Fernandez, Gang Han, Serena Wong, Malini Harigopal, Mirna Podoll, Kamaljeet Singh, Amy Ly, M Gabriela Kuba, Hannah Wen, Mary Ann Sanders, Jane Brock, Shi Wei, Oluwole Fadare, Krisztina Hanley, Julie Jorns, Olivia L Snir, Esther Yoon, Kim Rabe, T Rinda Soong, Emily S Reisenbichler, and David L Rimm
First-Time Prescribing of GLP-1 Receptor Agonists from 2018-2023: A Descriptive Analysis, Patricia Rodriguez, Ty Gluckman, Nicholas L. Stucky, and See full list of authors in comments
Real-World Effectiveness of SGLT2 Inhibitors Vs Metformin As First-Line Therapy in Type 2 Diabetes, Patricia Rodriguez, Samuel Gratzl, Ryan Lee, Sarah Gilson, Peter Smits, Nicholas L Stucky, and Tyler J Gluckman
Real-World Effectiveness of SGLT2 Inhibitors Vs Metformin As First-Line Therapy in Type 2 Diabetes, PJ Rodriguez, Tyler Gluckman, and See full list of authors in comments
Comparative Effectiveness of Semaglutide and Tirzepatide for Weight Loss in Adults with Overweight and Obesity in the US: A Real-World Evidence Study, PJ Rodriguez, BM Goodwin Cartwright, S Gratzl, R Brar, C Baker, Tyler J Gluckman, and NL Stucky
First-Time Prescribing of GLP-1 Receptor Agonists from 2018-2023: A Descriptive Analysis, PJ Rodriguez, S Gratzl, BM Goodwin Cartwright, R Brar, Tyler J Gluckman, and NL Stucky
Abstract CT133: Trial in progress: a multicenter phase 1/1b dose escalation study of WTX-124 as a monotherapy and in combination with pembrolizumab in patients with selected advanced or metastatic solid tumors, I Rodriquez-Rivera, Brendan Curti, and See full list of authors in comments
Nivolumab Plus Ipilimumab in Patients With Solid Tumors With, Nitin Rohatgi, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Funda Meric-Bernstam, Evan Pisick, Olatunji B Alese, Christopher M Reynolds, Ramya Thota, Gina Vaccaro, Margaret von Mehren, Rebecca C Arend, Vi K Chiu, Herbert L Duvivier, Philip J Gold, Keely Hack, Alissa S Marr, Arthur Winer, Gina N Grantham, Dominique C Hinshaw, Abigail Gregory, Susan Halabi, and Richard L Schilsky
Intratumoral bacteria influence immunotherapy efficacy, AS Rolig, GH McGee, and Will Redmond
Antibiotic-induced yeast overgrowth impairs efficacy of aPD-1 immunotherapy, AS Rolig, GH McGee, and WL Redmond
Unsupervised mRNA-seq classification of heart transplant endomyocardial biopsies., Erick Romero, Esteban Tabak, Gregory Fishbein, Silvio Litovsky, Jose Tallaj, David Liem, Maral Bakir, Yeraz Khachatoorian, Brian Piening, Brendan Keating, Mario Deng, and Martin Cadeiras
Characterization of murine lymphocyte activation and exhaustion markers by a 14-color flow cytometry panel., Daniel Rose, Annah S Rolig, and William L. Redmond
One-Year Results of a Low-Profile Endograft in Acute, Complicated Type B Aortic Dissection., Peter J Rossi, Nimesh D Desai, S Chris Malaisrie, Sean P Lyden, Naiem Nassiri, T Brett Reece, Joshua D Adams, Sina L Moanie, Christian C Shults, RelayPro-D Investigators, and Brant Ullery (RelayPro-D Investigators)
Evaluation of an Integrated Intervention to Address Clinical Care and Social Needs Among Patients with Type 2 Diabetes., Sarah E Roth, Benjamin Gronowski, Kyle Jones, Rachel A Smith, Sonya Kauffman Smith, Keri B Vartanian, and Bill J. Wright
Assessing the impact of recovery housing on healthcare utilization in Portland, Oregon., Sarah E Roth, Kyle Jones, and Keri B Vartanian
Participant Perspectives on Community Health Workers' Critical Role in Their Experience of the Pathways Program to Address Complex Needs., Sarah E Roth, Katherine Marsi, Ben Gronowski, Hannah Cohen-Cline, and Natalie Kenton
Safety and efficacy of D-1553 in KRAS G12C-mutated colorectal cancer: Results from a phase I/II study, D-Y Ruan, Rachel Sanborn, and See all authors in comments
Robot-Assisted Transcranial Doppler Versus Transthoracic Echocardiography for Right to Left Shunt Detection., Mark N Rubin, Ruchir Shah, Thomas Devlin, Teddy S Youn, Michael F Waters, John J Volpi, Aaron Stayman, Colleen Douville, Ted Lowenkopf, Georgios Tsivgoulis, and Andrei V Alexandrov
Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in patients with advanced solid tumors., Charles M Rudin, Hardev S Pandha, Matthew Zibelman, Wallace L Akerley, Kevin J Harrington, Daphne Day, Andrew G Hill, Steven J O'Day, Timothy D Clay, Gavin M Wright, Ross R Jennens, David E Gerber, Jonathan E Rosenberg, Christy Ralph, David C Campbell, Brendan Curti, Jaime R Merchan, Yixin Ren, Emmett V Schmidt, Lisa Guttman, and Sumati Gupta
The 2023 International Society for Heart and Lung Transplantation Guidelines for Mechanical Circulatory Support: A 10- Year Update., Diyar Saeed, David Feldman, Aly El Banayosy, Emma Birks, Elizabeth Blume, Jennifer Cowger, Christopher Hayward, Ulrich Jorde, Jamila Kremer, Guy MacGowan, Simon Maltais, Simon Maybaum, Mandeep Mehra, Keyur B Shah, Paul Mohacsi, Martin Schweiger, Sarah E Schroeder, Palak Shah, Marvin Slepian, Laurens F Tops, Paulino Alvarez, Francisco Arabia, Saima Aslam, Louis Benson-Louis, Edo Birati, Holger W Buchholz, Ari Cedars, Dawn Christensen, Agnieszka Ciarka, Erin Coglianese, Rebecca Cogswell, Jennifer Cook, Jack Copeland, Jose Gonzalez Costello, Stavros G Drakos, Pirooz Eghtesady, Tonya Elliot, Jerry D Estep, Jaime-Juergen Eulert-Grehn, De Rita Fabrizio, Jens Garbade, Jill Gelow, Maya Guglin, Jaime Hernandez-Montfort, Doug Horstmanshof, Ranjit John, Manreet Kanwar, Feras Khaliel, Gene Kim, Sachin Kumar, Jacob Lavee, Marzia Leache, Pascal Leprince, Sern Lim, Antonio Loforte, Jiri Maly, Samer Najjar, Ivan Netuka, Salpy V Pamboukian, Snehal R Patel, Sean Pinney, Christina Vander Pluym, Evgenij Potapov, Desiree Robson, Yogita Rochlani, Stuart Russell, Kristin Sandau, Elena Sandoval, Gabriel Sayer, Sarah Schettle, David Schibilsky, Thomas Schlöglhofer, Jan Schmitto, Aleem Siddique, Scott Silvestry, Mark S Slaughter, Benjamin Sun, Hiroo Takayama, Ryan Tedford, Jeffrey J Teuteberg, Van-Khue Ton, Nir Uriel, Juliane Vierecke, Daniel Zimpfer, and David D'Alessandro
Multi-center real-world data curation and assessment of tumor growth rate and overall survival in advanced NSCLC treated with PD-(L)1 immune checkpoint inhibitor therapy, C Sako, Brendan Curti, Roshanthi Weerasignhe, and See all authors in comments
In-Person vs Virtual Interview Format for Fellowships in Cardiovascular Disease: A Nationwide Survey of Fellows-in-Training., Jonathan R Salik, Emily K Zern, Inbar R McCarthy, Paul Theriot, Kristin West, Prashanth Thakker, Gaby Weissman, and Lisa J Rose-Jones
Immune Pathway Antagonists, R Sanborn
Adjuvant/Neoadjuvant/Perioperative A (Whirlwind) Tour of Recent Developments in Early-Stage NSCLC, Rachel Sanborn
Does Finding a Rare Mutation Accomplish Anything, Rachel Sanborn
Personalizing Management of Early-Stage NSCLC. Sanborn R. APP Oncology Summit; 2023 October 8; Portland, OR., Rachel Sanborn
Phase 1/2 study of the hexavalent OX40 agonist INBRX-106 alone and in combination with pembrolizumab in select solid tumors, Rachel Sanborn
The Role of SHP-2 Inhibitors Alone or in Combination, Rachel Sanborn
2166 / 8 - Analysis of ctDNA next generation sequencing (NGS) for predicting response to amivantamab and lazertinib among patients with EGFR-mutant NSCLC after progression on osimertinib and platinum-based chemotherapy (CHRYSALIS-2 Cohort A), Rachel E Sanborn and See full list of authors in comments
NSCLC with MET Amplification (METamp): Epidemiology, Disease Characteristics, Testing Procedures, and Economic and Humanistic Burden – a Targeted Literature Review, Rachel Sanborn and See all authors in comments
Phase 1/2 study of the hexavalent OX40 agonist INBRX-106 alone and in combination with pembrolizumab in select solid tumors, Rachel Sanborn and See full list of authors in comments
Breast Cancer Immunology, SE Sanborn
Immunology 101, SE Sanborn
Hybrid repair of an innominate artery pseudoaneurysm after blunt traumatic injury in a bovine arch., Keyuree Satam, Sabina Sorondo, Michael Paisley, and Venita Chandra
Nursing Waste Reduction for a Healthy Environment, Elizabeth Schenk, Sarah Johnson, Brandi Kelley-Gustafson, and Oriana Turley
Preoperative Treatment of Locally Advanced Rectal Cancer., Deborah Schrag, Qian Shi, Martin R Weiser, Marc J Gollub, Leonard B Saltz, Benjamin L Musher, Joel Goldberg, Tareq Al Baghdadi, Karyn A Goodman, Robert R McWilliams, Jeffrey M Farma, Thomas J George, Hagen F Kennecke, Ardaman Shergill, Michael Montemurro, Garth D Nelson, Brian Colgrove, Vallerie Gordon, Alan P Venook, Eileen M O'Reilly, Jeffrey A Meyerhardt, Amylou C Dueck, Ethan Basch, George J Chang, and Harvey J Mamon
PROSPECT: A randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by total mesorectal excision (TME) for treatment of locally advanced rectal cancer (LARC) (Alliance N1048), D Schrag, HF Kennecke, and See all authors in comments
Oral Gauze for Bleeding Control in Perioral and Perinasal Dermatologic Surgery., Riyad N H Seervai, Jose A Cervantes, Ikue Shimizu, and Ida F Orengo
Sex Differences in pLVAD-Assisted High-Risk Percutaneous Coronary Intervention: Insights From the PROTECT III Study., Tayyab Shah, Arsalan Abu-Much, Wayne B Batchelor, Cindy L Grines, Suzanne J Baron, Zhipeng Zhou, Yanru Li, Aneel S Maini, Björn Redfors, Yasin Hussain, Jason R Wollmuth, M Babar Basir, William W O'Neill, and Alexandra J Lansky
The immunogenic radiation and new players in immunotherapy and targeted therapy for head and neck cancer., Shay Sharon, Narmeen Daher-Ghanem, Deema Zaid, Michael J Gough, and Nataly Kravchenko-Balasha
A phase Ib study of interleukin-2 plus pembrolizumab for patients with advanced melanoma., Ann W Silk, Brendan Curti, Jennifer Bryan, Tracie Saunders, Weichung Shih, Michael P Kane, Phoebe Hannon, Christopher B Fountain, Jessica Felcher, Andrew Zloza, Howard L Kaufman, Janice M Mehnert, and David F McDermott
AI-based radiomic biomarkers to predict PD-(L)1 immune checkpoint inhibitor response within PD-L1 high/low/negative expression categories in stage IV NSCLC., George R. Simon, Brendan Curti, Roshanthi Weerasinghe, and See all authors in comments
Association of nutrition with psychological health and quality of life among older adults with advanced cancer, Surbhi Singhal, Alison Conlin, and See full list of authors in comments
Impact of Patient Characteristics and COVID 19 on Last Known Well to Arrival, T Singh, Alyx Lesko, and See all authors in comments
Modulation of myeloid and T cells in vivo by Bruton's tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinoma., Meenal Sinha, Courtney Betts, Li Zhang, Madeline J Griffith, Isabelle Solman, Brandon Chen, Eric Liu, Whitney Tamaki, Jacob Stultz, Jaqueline Marquez, Shamilene Sivagnanam, Alexander Cheung, Denise Pener, Anne Fahlman, Erin Taber, Kimberly Lerner, Matthew Crocker, Kendra Todd, Brindha Rajagopalan, Clarisha Ware, Mark Bridge, Johnson Vo, Hannah Dragomanovich, Julie Sudduth-Klinger, Gina Vaccaro, Charles D Lopez, Margaret Tempero, Lisa M Coussens, and Lawrence Fong
Impact of Fall Education to Nursing Staff on Oncology Patient Fall Rates, Danni Sloane
Evaluating the efficacy and safety of transitioning patients with multiple sclerosis from natalizumab to ocrelizumab (OCTAVE)., Kyle Smoot, Horia Marginean, Tiffany Gervasi-Follmar, Chiayi Chen, Pavle Repovic, and Stanley Cohan
Facial nerve palsy: An early sign of COVID-19., Michael Somero, Elisa Akagi, and Ashish Bhargava
Phenotyping sub-populations of heart failure patients based on clinical and social determinants of health using unsupervised machine learning models, Kateri Spinelli, HF Li, Jacob Abraham, X Huang, and See full list of authors in comments
Impact of Adherence to Operative Standards and Stage-Specific Guideline-Recommended Therapy in Nonmetastatic Pancreatic Adenocarcinoma., Holly V Spitzer, Phillip M Kemp Bohan, Elizabeth L Carpenter, Alexandra M Adams, Shu-Ching Chang, Gary Grunkemeier, Timothy J Vreeland, Ching-Wei D Tzeng, Matthew H G Katz, and Daniel W Nelson
Allogeneic Chimeric Antigen Receptor T (CAR-T) cell Immunotherapy Targeting CD70 Tumor Antigen in Patients with Metastatic Clear Cell Renal Cell Carcinoma., S Srour, Brendan Curti, and See full list of authors in comments
Breast Cancer Vaccine Landscape. Stanton S. SABCS Annual Meeting; 2023 December 5; San Antonio, TX., Sasha Stanton
Retinoid X receptor agonists enhances type I systemic and intratumoral immunity, but enhanced tumor prevention, with the HER2-IGFBP2-IGF1R plasmid vaccine in two mouse mammary tumor models, Sasha Stanton and See full list of authors in comments
Antigen Identification and Preventive Vaccine Development for Pre-Malignant Breast Lesions, SE Stanton
Clinical Trials: Patient Selection, Design, and Endpoints, SE Stanton
How does immunotherapy and your immune system work together to destroy cancer cells, SE Stanton
Primary Immunoprevention Strategies, SE Stanton
Rexinoids in Breast Cancer Prevention, SE Stanton
The Simplified Extraction of Atrial Tumor With Targeted Loop Electricity (SEATTLE) Procedure., Zachary L Steinberg, David Elison, Logan L Vincent, Donald Oxorn, and James M McCabe
Developments in Checkpoint Inhibitor Therapy for the Management of Deficient Mismatch Repair (dMMR) Rectal Cancer., Alan Su, Rodrigo Pedraza, and Hagen F Kennecke
Differences in US Regional Healthcare Allocation Guidelines During the COVID-19 Pandemic., Donald R Sullivan, Nandini Sarma, Catherine L Hough, Richard A Mularski, Molly L Osborne, Kevin M. Dirksen, and Robert C Macauley
Discordance in Total Mesorectal Excision Specimen Grading in a Prospective Phase 2 Multicenter Rectal Cancer Trial: Are We Overestimating the Quality of Our Resections?, Patricia Sylla, Mariana Berho, Dana Sands, Alison Ricardo, Antoinette Bonaccorso, Erin Moshier, Elisabeth Hain, Riva Letchinger, John Marks, Mark Whiteford, Elisabeth Mclemore, Justin Maykel, Karim Alavi, Karen Zaghiyan, Sami Chadi, Sherief F Shawki, Scott Steele, Alessio Pigazzi, Matthew Albert, Teresa DeBeche-Adams, Alexandros Polydorides, and Steven Wexner
Multicenter phase II trial of transanal total mesorectal excision for rectal cancer: preliminary results., Patricia Sylla, Dana Sands, Alison Ricardo, Antoinette Bonaccorso, Alexandros Polydorides, Mariana Berho, John Marks, Justin Maykel, Karim Alavi, Karen Zaghiyan, Mark Whiteford, Elisabeth Mclemore, Sami Chadi, Sherief F Shawki, Scott Steele, Alessio Pigazzi, Matthew Albert, Teresa DeBeche-Adams, Erin Moshier, and Steven D Wexner
Pregnancy and Heart Health: The 9 months and beyond, LM Tam
Hospital-Based, Community Teaching Kitchen Integrates Diabetes Education, Culinary Medicine, and Food Assistance: Case Study During the COVID-19 Pandemic., Jacob P Tanumihardjo, Heidi Davis, Jill Christensen, Rachel A Smith, Sonya Kauffman Smith, and Kathryn E Gunter
Enhancing Chronic-Disease Education through Integrated Medical and Social Care: Exploring the Beneficial Role of a Community Teaching Kitchen in Oregon., Jacob P Tanumihardjo, Heidi Davis, Mengqi Zhu, Helen On, Kayla K Guillory, and Jill Christensen
Analysis of Radiation Therapy Quality Assurance in NRG Oncology RTOG 0848., Leila T Tchelebi, Kathryn A Winter, Ross A Abrams, Howard P Safran, William F Regine, Susan McNulty, Abraham Wu, Kevin L Du, Samantha A Seaward, Shelly X Bian, Raid Aljumaily, Anand Shivnani, Jeanna L Knoble, Todd S Crocenzi, Thomas A DiPetrillo, Kevin S Roof, Christopher H Crane, and Karyn A Goodman
Use of a Pulmonary Artery Pressure Sensor to Manage Patients With Left Ventricular Assist Devices., Vinay Thohan, Jacob Abraham, Adam Burdorf, Nasir Sulemanjee, Brian Jaski, Maya Guglin, Francis D Pagani, Himabindu Vidula, David T Majure, Rebecca Napier, Thomas J Heywood, Rebecca Cogswell, Nicholas Dirckx, David J Farrar, Stavros G Drakos, and INTELLECT 2-HF Investigators
